| Medicare Wellpoint NGS | Billing and Coding: Omalizumab and biosimilar, OMLYCLO® (omalizumab-igec) (52448) | 2026-07-14 |
| Medicare Wellpoint NGS | Billing and Coding: Paclitaxel (e.g., Taxol®/Abraxane ™) (52450) | 2026-07-14 |
| Medicare Wellpoint NGS | Billing and Coding: Luteinizing Hormone-Releasing Hormone (LHRH) Analogs (52453) | 2026-07-14 |
| Medicare Wellpoint NGS | Psychological Services Coverage under the Incident to Provision for Physicians and Non-physicians – Medical Policy Article (52825) | 2026-07-14 |
| Medicare Wellpoint NGS | Blepharoplasty - Medical Policy Article (52837) | 2026-07-14 |
| Medicare Wellpoint NGS | Clinical Trials – Medical Policy Article (52840) | 2026-07-14 |
| Medicare Wellpoint NGS | Investigational Device Exemption Requests - Medical Policy Article (52841) | 2026-07-14 |
| Medicare Wellpoint NGS | Local Coverage Determination (LCD) Reconsideration Process - Medical Policy Article (52842) | 2026-07-14 |
| Medicare Wellpoint NGS | Home Health Skilled Nursing Care: Teaching and Training for Dementia Patients with Behavioral Disturbances - Medical Policy Article (52845) | 2026-07-14 |
| Medicare Wellpoint NGS | Billing and Coding: Breast Imaging: Breast Echography (Sonography)/Breast MRI/Ductography (52849) | 2026-07-14 |